Summary: The FDA approved a new one-shot vaccine made by Johnson & Johnson, which could help accelerate the pace of vaccinations to prevent covid-19. But after a dramatic decline, case numbers are again rising and several states are rolling back public health mitigation efforts. Mary Ellen McIntire of CQ Roll Call, Joanne Kenen of Politico and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Jordan Rau, about the latest KHN-NPR “Bill of the Month” episode.
